The incidence of esophageal cancer, namely the adenocarcinoma subtype, continues to
increase exponentially on an annual basis. The indolent nature of the disease renders a …

The absolute incidence of esophageal adenocarcinoma has increased 7-fold over the past 5
decades, and esophageal adenocarcinoma is the most rapidly increasing epithelial …

Although the outcome for advanced stage esophageal cancer is poor, the early detection
and treatment of early stage disease is usually associated with a much better outcome. Until …

At present there are no clear guidelines for the treatment of early esoph-ageal cancer,
probably because the early tumor stages were seen infrequently in the past [1–5]. Because …

Careful staging is indispensable before curative endoscopic therapy, as is consistent and
careful follow-up. Endoscopic therapy is safe and effective, and endoscopic resection is the …

Esophageal cancers have traditionally been diagnosed late and prognosis has been dire.
For many years the only real treatment option was esophagectomy with substantial morbidity …

Esophageal carcinoma affects more than 450000 people worldwide and the incidence is
rapidly increasing. In the United States and Europe, esophageal adenocarcinoma has …

Esophageal cancer (EC) often cannot be discovered in time because of its asymptomatic or
symptom-atypical characteristics in early stage. The risk and probability of lymph node …

The incidence of esophageal adenocarcinoma is on the rise. With advances in endoscopic
techniques and imaging technology, early neoplastic lesions are being increasingly …

Esophageal carcinoma is a highly lethal cancer associated with high morbidity and mortality.
Esophageal squamous cell carcinoma and esophageal adenocarcinoma are the two distinct …